Galmed Pharmaceuticals Ltd. (EOCN): Total Assets
$18.63M
As of 2025-12-31
+4.0%
3-year compound annual growth
-18.7%
5-year compound annual growth
-2.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $18.63M | +0.7% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $18.50M | +11.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $16.63M | +0.4% | 2025-04-02, Balance as of period end |
| 2022-12-31 | $16.56M | -54.8% | 2024-04-04, Balance as of period end |
| 2021-12-31 | $36.60M | -30.1% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $52.38M | -32.1% | 2022-05-02, Balance as of period end |
| 2019-12-31 | $77.14M | -14.9% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $90.60M | +361.2% | 2020-03-12, Balance as of period end |
| 2017-12-31 | $19.64M | +19.4% | 2019-03-13, Balance as of period end |
| 2016-12-31 | $16.45M | -32.2% | 2018-03-13, Balance as of period end |
| 2015-12-31 | $24.26M | -26.3% | 2017-03-23, Balance as of period end |
| 2014-12-31 | $32.92M | n/m | 2016-03-22, Balance as of period end |
| 2013-12-31 | $166.0K | n/a | 2015-03-31, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $18.63M | +0.7% |
| Lite Strategy, Inc. (LITS) | 2025-06-30 | $18.29M | -55.8% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Genelux Corp (GNLX) | 2025-12-31 | $19.03M | -45.2% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| Clene Inc. (CLNN) | 2025-12-31 | $18.13M | -33.7% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $19.27M | -59.5% |
| Galectin Therapeutics Inc (GALT) | 2025-12-31 | $19.53M | +11.6% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $17.74M | -49.3% |
Compare EOCN, LITS, ALLR, GNLX side by side · Screen every company in Pharmaceutical Preparations ↗